Bookmark and Share

Publications - Other Viruses

Clements ML, Wisseman CL, Woodward TE Jr, Fiset P, Dumler JS, McNamee W, Black RE, Rooney J, Hughes TP, Levine MM. Reactogenicity, Immunogenicity, and Efficacy of a Chick Embryo Cell-Derived Vaccine for Rocky Mountain Spotted Fever. J. Infect. Dis. 1983;148:922-930.

Clements ML, Dumler JS, Fiset P, Wisseman CL Jr, Levine MM. Serodiagnosis of rocky mountain spotted fever: comparison of IgM and IgG enzyme-linked immunosorbent assay and indirect fluorescent antibody test. J. Infect. Dis. 1983;148:876-880.

Hsia J, Goldstein AL, Simon GL, Sztein MB and Hayden FG. Peripheral blood mononuclear cell interleukin-2 and interferon-( production, cytotoxicity and antigen-stimulated blastogenesis during experimental rhinovirus infections. J. Infect. Dis. 1990;162:591-597.

Kotloff KL, Losonsky GA, Morris JG, Wasserman SS, Singh-Naz N, Levine MM. Enteric adenovirus infection and childhood diarrhea: an epidemiologic study in three clinical settings. Pediatrics 1989;84:219-225.

Vial PA, Kotloff KL, Tall BD, Morris JG, Levine MM. Detection by immune electron microscopy of 27-nm viral particles associated with community-acquired diarrhea in children. J. Infect. Dis. 1990;161:571-3.

Onorato I, Modlin JF, McBean AM, Thomas ML, Losonsky GA, Bernier RH. Mucosal immunity induced by enhanced potency of IPV and OPV. J. Infect. Dis. 1991;160:25-31.

Kotloff KL, Herrmann JE, Blacklow NR, Hudson RW, Wasserman SS, Morris JG, Levine MM. The frequency of astrovirus as a cause of diarrhea in Baltimore children. Pediatr Infect Dis J 1992;11:587-589.

Tacket C., Losonsky G., Lubeck M., Davis A., Mizutani S., Horwith G., Hung P., Edelman R., Levine M. Initial safety and immunogenicity studies of an oral recombinant adenohepatitis vaccine. Vaccine 1992;10:673-676.

Darwish, M.A., Raouf, T.A., Rushdy, P., Constantine, N.T., Rao, M.R., Edelman, R. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am. J. Trop Med. Hyg. 1993, 49:440-447.

Green, S, Kurane, I, Edelman, R, Tacket, CO, Eckels, KH, Vaughn, DW, Hoke, CH, and Ennis, FA. Dengue virus-specific human CD4+ T Lymphocyte responses in a recipient of an experimental live-attenuated Dengue 1 vaccine: bulk culture and clonal analysis and precursor frequency determination. J. Virol. 1993, 67:5962-5967.

Zivny, J., Kurane, I., Tacket, C.O., Edelman, R., Ennis, F. Dengue virus-specific, human CD4+ cytotoxic T lymphocytes (CTL) generated in short term culture: CD4+ CTL activity augmented by IL-4 and IL-7, and suppressed by TGF-ß. Viral Immunol. 1993, 6:143-151.

Hibbs, R.G., Corwin, A.L., Hassan, N.F., Kamel, M., Darwish, M., Edelman, R., Constantine, N., Rao, M.R., Khalifa, A.S., Mokhtar, S., Fam, N.S., Ekladious, E.M., Bassily, S.B. The epidemiology of Hepatitis C antibody in Egypt. J. Infect. Dis. 1993,168:789-790.

Edelman R, Tacket CO, Wasserman SS, Vaughn DW, Eckels KH, Dubois DR, Summers PL, Hoke CH. A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans. Journal of Infectious Diseases, 1994, 170:1448-1455.

Darwish MA, Faris R, Clemens JD, Rao MR, Edelman R. High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study. Am. J. Trop. Med. Hyg. 1996;54:554-558.

Iyengar S, Shah KV, Kotloff KL, Ghim SJ, Viscidi RP. Self-assembly of in vitro-translated human papillomavirus type 16 L1 capsid protein into virus-like particles and antigenic reactivity of the protein. Clin. Diagn. Lab. Immunol. 1996;3:733-739.

Murphy EL, Wilks R, Hanchard B, Cranston B, Figueroa JP, Gibbs WN, Murphy J, Blattner WA. A case-control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-I) in Jamaica. Int. J. Epidemiol. 1996;25:1083-1089.

Murphy EL, Wilks R, Morgan OS, Hanchard B, Cranston B, Figueroa JP, Gibbs WN, Murphy J, Blattner WA. Health effects of human T-lymphoTrop. ic virus type I (HTLV-I) in a Jamaican cohort. Int. J. Epidemiol. 1996;25:1090-1097.

Iyengar S, Shah KV, Kotloff KL, Ghim SJ, Viscidi RP. Self-assembly of in vitro-translated human papillomavirus type 16 L1 capsid protein into virus-like particles and antigenic reactivity of the protein. Clin. Diagn Lab Immunol 1996;3:733-739.

Lechat MF, Shrager DI, Declercq E, Bertrand F, Blattner WA, Blumberg BS. Decreased survival of HTLV-I carriers in leprosy patients from the Democratic Republic of the Congo: a historical prospective study. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1997;15:387-390.

Rennels MB. Rotavirus vaccine comes of age. J. Pediatr. 1997;131:512-513.

Rennels MB. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. J. Infect. Dis. 1996;174 Suppl 1:S107-111.

Rennels MB, Ward RL, Mack ME, Zito ET. Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group. J. Infect. Dis. 1996;173:306-313.

Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET, Mack ME, Davidson BL, Kapikian AZ. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group. Pediatrics 1996;97:7-13.

Viscidi RP, Kotloff KL, Clayman B, Russ K, Shapiro S, Shah KV. Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women. Clin. Diagn. Lab. Immunol. 1997;4:122-126.

Kotloff KL, Wasserman SS, Russ K, Shapiro S, Daniel R, Brown W, Frost A, Tabara SO, Shah K. Detection of genital human papillomavirus and associated cytological abnormalities among college women. Sex. Transm. Dis. 1998;25:243-50.

Ablashi D, Chatlynne L, Cooper H, Thomas D, Yadav M, Norhanom AW, Chandana AK, Churdboonchart V, Kulpradist SA, Patnaik M, Liegmann K, Masood R, Reitz M, Cleghorn F, Manns A, Levine PH, Rabkin C, Biggar R, Jensen F, Gill P, Jack N, Edwards J, Whitman J, Boshoff C. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Brit. J. Cancer. 1999;81:893-7.

Losonsky GA, Wasserman SS, Stephens I, Mahoney F, Armstrong P, Gumpper K, Dulkerian S, West DJ, Gewolb IH. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization. Pediatrics. 1999;103:E14.

Manns A, Miley WJ, Waters D, Hanchard B, Wharfe G, Cranston B, Williams E, Blattner WA. Prognostic significance of quantitative viral markers in adult T-cell leukemia/lymphoma. Blood 1999;94:372-3.

Pombo De Oliveira MS, Loureiro P, Bittencourt A, Chiattone C, Borducchi D, De Carvalho SM, Barbosa HS, Rios M, Sill A, Cleghorn F, Blattner W. Geographic diversity of adult t-cell leukemia/lymphoma in Brazil. The Brazilian ATLL Study Group. Int. J. Cancer. 1999;83:291-8.

Strickler HD, Viscidi R, Escoffery C, Rattray C, Kotloff KL, Goldberg J, Manns A, Rabkin C, Daniel R, Hanchard B, Brown C, Hutchinson M, Zanizer D, Palefsky J, Burk RD, Cranston B, Clayman B, Shah KV. Adeno-associated virus and development of cervical neoplasia. J. Med Virol. 1999;59:60-5.

Tacket CO, Roy MJ, Widera G, Swain WF, Broome S, Edelman R. Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine. 1999;17:2826-9.

Edelman DC, Ketema F, Saville RD, Herman J, Sill AM, Gill PS, Blattner WA, Constantine NT. Specifics on the refinement and application of two serological assays for the detection of antibodies to HHV-8. J Clin Virol. 2000, 16:225-37.